Literature DB >> 11214613

Primary carcinoma of the fallopian tube. A report of 19 cases with literature review.

C Schneider1, E Wight, D Perucchini, U Haller, D Fink.   

Abstract

Primary carcinoma of the fallopian tube is the rarest cancer of the female genital tract with an incidence of 0.5% of all gynecologic tumors. Since the first report in 1847 about 1,500 cases have been published. Due to similarity of the clinical presentation the staging and therapeutic management have been adapted to that of ovarian cancer. We retrospectively evaluated all the 19 patients who had been diagnosed with primary carcinoma of the fallopian tube at the Department of Obstetrics and Gynecology of the University of Zurich between 1977 and 1998. All lesions were staged according to the rules of FIGO adopted in 1991. At the time of diagnosis the median age was 62 (46-87) years. Twelve (63%) women revealed FIGO stage III-IV, whereas four (21%) and three (16%) patients were diagnosed in stage I and stage II, respectively. Eight (42%) women were nullipara. Histology showed serous-papillary carcinoma, in ten (53%) cases. The 5-year survival rate was 22% for all FIGO stages and 80% for stage I. None of the patients with stage III and IV survived 5 years. Ovarian cancer and primary carcinoma of the fallopian tube are similar in many aspects. Both carcinomas have a similar age distribution, show an increase among nulliparous women, are often of serous papillary histology, have a poor prognosis with stage and residual tumor size as important prognostic factors, and respond initially well to platinum-based chemotherapy. Nevertheless, there appears to be a difference between the two diseases: primary carcinoma of the fallopian tube is more often diagnosed in an earlier stage. This many be due to lower abdominal pain resulting from tubal dilatation and to abnormal bloody-watery discharge.

Entities:  

Mesh:

Year:  2000        PMID: 11214613

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

1.  Paraneoplastic Neurological Syndrome in Fallopian Tube Cancer.

Authors:  E Maas; T Skoberne; A Werner; S Braun; C Jackisch
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-10       Impact factor: 2.915

2.  Prognostic Significance of Retroperitoneal Lymphadenectomy, Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Primary Fallopian Tube Carcinoma: A Multicenter Study.

Authors:  Kemal Gungorduk; Ibrahim E Ertas; Aykut Ozdemir; Emrah Akkaya; Elcin Telli; Salih Taskin; Mehmet Gokcu; Ahmet Baris Guzel; Tufan Oge; Levent Akman; Tayfun Toptas; Ulas Solmaz; Askın Dogan; Mustafa Cosan Terek; Muzaffer Sanci; Aydin Ozsaran; Tayyup Simsek; Mehmet Ali Vardar; Omer Tarik Yalcin; Sinan Ozalp; Yusuf Yildirim; Firat Ortac
Journal:  Cancer Res Treat       Date:  2014-11-17       Impact factor: 4.679

3.  Sonographic Diagnosis of Tubal Cancer with IOTA Simple Rules Plus Pattern Recognition

Authors:  Theera Tongsong; Chanane Wanapirak; Charuwan Tantipalakorn; Dangcheewan Tinnangwattana
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

4.  Prognostic factors of primary fallopian tube carcinoma.

Authors:  Emrah Akkaya; Muzaffer Sanci; Nur G Kulhan; Mehmet Kulhan; Umit Nayki; Cenk Nayki; Nahit Ata; Pasa Ulug
Journal:  Contemp Oncol (Pozn)       Date:  2018-04-09

5.  Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.

Authors:  R I Olivier; M van Beurden; M A C Lubsen; M A Rookus; T M Mooij; M J van de Vijver; L J van't Veer
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

6.  Clinical and survival analysis of 36 cases of primary fallopian tube carcinoma.

Authors:  Ying Ma; Wei Duan
Journal:  World J Surg Oncol       Date:  2014-10-12       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.